At a glance
- Originator Pierre Fabre
- Class Antiparkinsonians; Benzopyrans; Imidazoles; Neuroprotectants; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Cognition disorders